Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sébastien Malinge

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Critical Reviews in Oncogenesis|December 14, 2011
Myeloid leukemia in Down syndromeIrum Khan, Sébastien Malinge, John Crispino
Blood|January 14, 2009
Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndromeSébastien Malinge, Shai Izraeli, John D Crispino
Molecular & Cellular Oncology|December 7, 2017
Molecular pathways driven by ETO2-GLIS2 in aggressive pediatric leukemiaCécile Thirant, Cécile Lopez, Sébastien Malinge, et al.
Leukemia|May 21, 2020
Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndromeAnouchka P Laurent, Rishi S Kotecha, Sébastien Malinge
Cancer Metastasis Reviews|September 18, 2025
Perspectives on the origin and therapeutic opportunities in Down syndrome-associated leukemiaKunjal Panchal, Jesse Armitage, Laurence C Cheung, et al.
Trends in Cancer|September 5, 2017
Pediatric Acute Megakaryoblastic Leukemia: Multitasking Fusion Proteins and Oncogenic CooperationsCécile K Lopez, Sébastien Malinge, Muriel Gaudry, et al.
International Journal of Molecular Sciences|July 13, 2024
Insights into the Clinical, Biological and Therapeutic Impact of Copy Number Alteration in CancerShannon L Carey-Smith, Rishi S Kotecha, Laurence C Cheung, et al.
The Journal of Clinical Investigation|February 23, 2012
Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndromeSébastien Malinge, Meghan Bliss-Moreau, Gina Kirsammer, et al.
Cancer Genetics and Cytogenetics|January 28, 2003
A subgroup of malignant fibrous histiocytomas is associated with genetic changes similar to those of well-differentiated liposarcomasFrédéric Chibon, Odette Mariani, Josette Derré, et al.
The Journal of Experimental Medicine|May 27, 2015
DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3Benjamin J Thompson, Rahul Bhansali, Lauren Diebold, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Critical Reviews in Oncogenesis|December 14, 2011
Myeloid leukemia in Down syndromeIrum Khan, Sébastien Malinge, John Crispino
Blood|January 14, 2009
Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndromeSébastien Malinge, Shai Izraeli, John D Crispino
Molecular & Cellular Oncology|December 7, 2017
Molecular pathways driven by ETO2-GLIS2 in aggressive pediatric leukemiaCécile Thirant, Cécile Lopez, Sébastien Malinge, et al.
Leukemia|May 21, 2020
Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndromeAnouchka P Laurent, Rishi S Kotecha, Sébastien Malinge
Cancer Metastasis Reviews|September 18, 2025
Perspectives on the origin and therapeutic opportunities in Down syndrome-associated leukemiaKunjal Panchal, Jesse Armitage, Laurence C Cheung, et al.
Trends in Cancer|September 5, 2017
Pediatric Acute Megakaryoblastic Leukemia: Multitasking Fusion Proteins and Oncogenic CooperationsCécile K Lopez, Sébastien Malinge, Muriel Gaudry, et al.
International Journal of Molecular Sciences|July 13, 2024
Insights into the Clinical, Biological and Therapeutic Impact of Copy Number Alteration in CancerShannon L Carey-Smith, Rishi S Kotecha, Laurence C Cheung, et al.
The Journal of Clinical Investigation|February 23, 2012
Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndromeSébastien Malinge, Meghan Bliss-Moreau, Gina Kirsammer, et al.
Cancer Genetics and Cytogenetics|January 28, 2003
A subgroup of malignant fibrous histiocytomas is associated with genetic changes similar to those of well-differentiated liposarcomasFrédéric Chibon, Odette Mariani, Josette Derré, et al.
The Journal of Experimental Medicine|May 27, 2015
DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3Benjamin J Thompson, Rahul Bhansali, Lauren Diebold, et al.
Pageof 3